Krsnaa Diagnostics Ltd vs Suven Life Sciences Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Krsnaa Diagnostics Ltd is ₹ 497.75 as of 23 Oct 15:30 . The P/E Ratio of Krsnaa Diagnostics Ltd changed from 22.3 on March 2022 to 16.7 on March 2026 . This represents a CAGR of -5.62% over 5 yearsThe P/E Ratio of Suven Life Sciences Ltd changed from 0 on March 2021 to 0 on March 2026 . This represents a CAGR of 0.0% over 6 years The Market Cap of Krsnaa Diagnostics Ltd changed from ₹ 1524 crore on March 2022 to ₹ 1690 crore on March 2026 . This represents a CAGR of 2.09% over 5 yearsThe Market Cap of Suven Life Sciences Ltd changed from ₹ 896.07 crore on March 2021 to ₹ 3503 crore on March 2026 . This represents a CAGR of 25.51% over 6 years The revenue of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 242.78 crore as compare to the Mar '26 revenue of ₹ 224.1 crore. This represent the growth of 8.34% The revenue of Suven Life Sciences Ltd for the Jun '26 is ₹ 11.09 crore as compare to the Mar '26 revenue of ₹ 8.3 crore. This represent the growth of 33.61% The ebitda of Krsnaa Diagnostics Ltd for the Jun '26 is ₹ 65.23 crore as compare to the Mar '26 ebitda of ₹ 86.37 crore. This represent the decline of -24.48% The ebitda of Suven Life Sciences Ltd for the Jun '26 is ₹ -124 crore as compare to the Mar '26 ebitda of ₹ -43.86 crore. This represent the growth of 184.95% The net profit of Krsnaa Diagnostics Ltd changed from ₹ 17.92 crore to ₹ 16.55 crore over 9 quarters. This represents a CAGR of -3.47% The net profit of Suven Life Sciences Ltd changed from ₹ -28.04 crore to ₹ -127 crore over 9 quarters. This represents a CAGR of 96.11% The Dividend Payout of Krsnaa Diagnostics Ltd changed from 11.1 % on March 2022 to 6.32 % on March 2026 . This represents a CAGR of -10.65% over 5 yearsThe Dividend Payout of Suven Life Sciences Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited' at Pune, Maharashtra dated December 22, 2010.
The Company name was changed to Krsnaa Diagnostics Private Limited', pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015.
Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India.
The Company is providing Radiology and Pathology services for X-ray, CT Scan, MRI, Mammography, Bone Densitometry, Ultrasound, Colout Doppler, Tele-Reporting services, all type of blood and urine investigation and other related diagnostic services.

About Suven Life Sciences Ltd

Suven Life Sciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated in March, 1989.
The Company changed its name from Suven Pharmaceuticals Limited to Suven Life Sciences Limited in September, 2003.
Promoted by Venkateswarlu Jasti, Company began its operations in 1989 as specialty chemicals provider. The Company is a clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of novel therapeutics for the treatment of neurodegenerative disorders.
Suven has a wholly owned subsidiary, Suven Neurosciences, Inc., USA, focused on clinical development activities of Suven molecules from phase 2, Proof-of-Concept (POC) studies. The Company is in the business of Contract Research And Manufacturing Services (CRAMS), catering to the needs of global life science industry and fine chemical majors.

FAQs for the comparison of Krsnaa Diagnostics Ltd and Suven Life Sciences Ltd

Which company has a larger market capitalization, Krsnaa Diagnostics Ltd or Suven Life Sciences Ltd?

Market cap of Krsnaa Diagnostics Ltd is 1,614 Cr while Market cap of Suven Life Sciences Ltd is 7,397 Cr

What are the key factors driving the stock performance of Krsnaa Diagnostics Ltd and Suven Life Sciences Ltd?

The stock performance of Krsnaa Diagnostics Ltd and Suven Life Sciences Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Krsnaa Diagnostics Ltd and Suven Life Sciences Ltd?

As of October 24, 2026, the Krsnaa Diagnostics Ltd stock price is INR ₹497.75. On the other hand, Suven Life Sciences Ltd stock price is INR ₹261.8.

How do dividend payouts of Krsnaa Diagnostics Ltd and Suven Life Sciences Ltd compare?

To compare the dividend payouts of Krsnaa Diagnostics Ltd and Suven Life Sciences Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.